Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment. Short bowel syndrome (SBS) represents one of the most ...

This infographic summarizes the main aspects of this longitudinal study—the first study to analyze the changes caused by glucagon-like peptide-2 (GLP-2) analogs to the intestinal environment in ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are standard-of-care agents that provide potent glucose-lowering without hypoglycemia, together with weight reduction and cardiovascular and renal ...

Patricia Louis is a content editor and social media strategist with a strong background in journalism, public relations and business. As the organic social media editor, she oversees and develops ...